Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line

Gliomas are the most frequently occurring primary tumor in the brain. The most malignant form of glioma, glioblastoma multiforme (GBM), is characterized by rapid and invasive growth and is restricted to the central nervous system (CNS). The transforming growth factor β2 (TGFβ2)/small mothers against decapentaplegic (Smad) signaling pathway is important, not only in GBM cell metabolism and invasion, but also in GBM cell proliferation. However, the functions of the downstream mediators of the TGFβ2/Smads signaling pathway remain to be fully elucidated. In the present study, short hairpin (sh)RNA interference was used to specifically inhibit the expression of Smad2 and Smad3 in the TGFβ2/Smad signaling pathway to investigate the effects of shRNA on the proliferation of human GBM cells. The results demonstrated that knockdown of either Smad2 or Smad3 enhanced cellular proliferation. Additionally, the key target genes involved in GBM cell proliferation, induced by TGFβ2, were found to be dependent on Smad3, but not Smad2.

[1]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[2]  C. Hill,et al.  Stoichiometry of Active Smad-Transcription Factor Complexes on DNA* , 2002, The Journal of Biological Chemistry.

[3]  Xin Tang,et al.  Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. , 2011, Experimental eye research.

[4]  Margaret Wrensch,et al.  Epidemiology and molecular pathology of glioma , 2006, Nature Clinical Practice Neurology.

[5]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[6]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[7]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[8]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[9]  Wei Zheng,et al.  Retinal vascular leakage occurring in GABA Rho-1 subunit deficient mice. , 2010, Experimental eye research.

[10]  S. Byers,et al.  The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer , 2005, Oncogene.

[11]  H. Lehnert,et al.  Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1 , 2011, Molecular Cancer.

[12]  Regulatory factor X 1 ‐ induced down ‐ regulation of transforming growth factor beta 2 transcription in human neuroblastoma cells , 2022 .

[13]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[14]  L. Salford,et al.  Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. , 2000, International journal of cancer.

[15]  Timothy C Ryken,et al.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.

[16]  B. Scheithauer,et al.  Distribution of transforming growth factor-β1 in human astrocytomas , 1992 .

[17]  E. Ortega,et al.  TGF-β: An Important Mediator of Allergic Disease and a Molecule with Dual Activity in Cancer Development , 2014, Journal of immunology research.

[18]  V. Balasubramaniyan,et al.  TGF-β as a therapeutic target in high grade gliomas - promises and challenges. , 2013, Biochemical pharmacology.

[19]  D. Brat,et al.  Newly Codified Glial Neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: Angiocentric Glioma, Pilomyxoid Astrocytoma and Pituicytoma , 2007, Brain pathology.

[20]  P. Kelly,et al.  Distribution of transforming growth factor-beta 1 in human astrocytomas. , 1992, Human pathology.

[21]  M. Inatani,et al.  Growth factors and their receptors in the retina and pigment epithelium , 1997, Progress in Retinal and Eye Research.

[22]  M. Weller,et al.  Targeting apoptosis pathways in glioblastoma. , 2013, Cancer letters.

[23]  J. Gauthier,et al.  A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 , 1999, Oncogene.

[24]  Alejandra Bruna,et al.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. , 2007, Cancer cell.

[25]  L. Salford,et al.  Expression of TGF‐β isoforms, TGF‐β receptors, and SMAD molecules at different stages of human glioma , 2000 .

[26]  S. Byers,et al.  The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. , 2005, Oncogene.

[27]  C. Feng,et al.  Regulatory Factor X1-induced Down-regulation of Transforming Growth Factor β2 Transcription in Human Neuroblastoma Cells* , 2012, The Journal of Biological Chemistry.

[28]  A. Nakao,et al.  Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor. , 2006, Journal of neurosurgery.